Mila’s life took a dramatic turn in 2018 when, at just 16 years old, she was diagnosed with myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS). This illness has confined her to a darkened room, making even the simplest tasks, like speaking, too exhausting for her to bear. She now communicates with her parents using pre-arranged gestures. The severity of the condition is such that what feels like a “cold, rough, dark tunnel” dominates her existence. “For me, it feels like you are walking through a cold, repellant, dark tunnel. And you go alone”, she says.

“Everything is gone that has made up the previous life.”

ME/CFS is a multisystemic disease, affecting several organ systems simultaneously. The symptoms can be debilitating, ranging from severe neurological pain to overwhelming cognitive dysfunction. For many patients, even minor intellectual or physical exertion can lead to a crisis – known as a “crash,” where the body is rendered almost completely dysfunctional on a cellular level. Seriously ill patients may completely lose the ability to perform basic functions like leaving the bed or speaking.

“It is extremely difficult to describe how such a body feels. The whole body feeling is gone. Body functions are gone, identity is gone, job is gone, friends are gone. Everything is gone that made up for the previous life. “
Director Sibylle Dahrendorf has been appearing on camera for years as a director and filmmaker to raise awareness of this condition that has greatly impacted her body.

Affected People are Completely Cut Off from Life

Documentaries like “Chronically ill, chronically ignored” highlight the suffering of patients worldwide. Made to get them a voice. The lack of adequate treatment, research, or tonally throughout the government and medical communities means these people remain significantly underserved. On a promising note, Long Covid has added millions of individuals to the ME/CFS discourse, leading to increased awareness and some funding, although it is still far from adequate.

The diagnosis of ME/CFS can vary and in some cases, may even completely absence. Even when a diagnosis is made, determining the causes can be a daunting task, and understanding the interactions between symptoms can take years. To put this into perspective, consider a high school student in America who falls ill with ME/CFS in 2023: what begins as a normal sick leave from school could extend indefinitely into a state of absolute isolation, akin to a life sentence to a confined space.

“I just waited to die.”

One such frightening outcome is reflected in the experiences of Asad Khan, a pulmonologist who became critically ill after contracting an unknown viral disease during the COVID-19 pandemic while treating patients.

“I was in this room, just waited to die. I couldn’t go on like this.”
Asad Khan

Blood washing, known as apheresis, provides a lifeline for many ME/CFS patients like Khan, where their blood is cleansed to remove toxins and impurities. Unfortunately, the health care system and health insurance plans in the United States don’t provide comprehensive coverage for every treatment needed. As Khan’s own struggle shows, discovering and funding successful treatment options proves challenging:

“It helped me a lot. But I know some people with whom it has hardly or not at all. It didn’t heal me either, but I am very grateful for the improvement.”
Khan emphasized that blood washing didn’t cure him, but it was a decisive intervention in their journey toward recovery.

There is More Commitment Needed for Illnesses like these

Despite the severity of its consequences, ME/CFS has historically attracted significantly less research and funding compared to diseases like cancer. For example, the unprecedented funding for cancer research worldwide has driven remarkable advancements in treatment and survival rates, contrasting sharply with the dearth of research and treatment options available for ME/CFS.
A case study of Sarah Boothby and Sean O’Neill, who lost their daughter Maeve to chronic illness. She was diagnosed with an unknown viral infection having previously maintained a fine health..

“She (Sarah Boothby) told them, Maeve has ME/CFS. Now we are all quite shaken. But today, we have to go into the bus.

Back at the ward, Maeve is struggling to speak, and her eyes are not focusing well.Finally, when Maeve can utter “I love you” to her parents, the doctors finally had a what seems to be, an easy diagnosis—concussion.
Sarah Boothby

The worldwide impact of chronic illnesses extends deeply into families, disrupting dreams and changing lives. Healthcare providers shouldn’t have to just sit idly by while diseases like this progress. Not even viruses like Corona exceeded the unpredictability and treatment inability of a diagnosed ME/CFS.

Progress crawls at a snail’s pace, and a disease like this with both mental and physical trauma means that research has to be even more innovative, yet discovering the underlying causes and effective treatments remains elusive with inadequate data on the exact number of sufferers.

Why the U.S. Needs to Take Action

To put into perspective, these conditions plaguing tens of millions of Americans warrant an urgent public health intervention. Biomarker research, sensor- based readiness to diagnose, and treatment options-backed up by an evolving knowledge of the human genome, backed up by inflation-based investment backed up against this hurdle needs.

The sheer dimensions and magnitude of these chronic diseases like the 1918 influenza make it even harder. Consequently, the national policy formulation goes as slow as the research. As we speak, we have still long to mitigate this formidable effort to bring millions further from the grip of this extremely long tunnel bringing them

Insights and Counterarguments

Some might argue that the focus on funding illnesses like cancer is justified due to their wide prevalence and immediately fatal outcomes. However, the exorbitant costs of treating ME/CFS in the long-term in otherwise healthy people make the need as compelling. Furthermore, with heightened awareness, more funds, and advanced telehealth care system in relocated hospitals. Compensation funds for researchers, researchers, and support groups should prove helpful:

Knowing an illness impacts humans through several factors including financial and psychological makes a marked improvement in the way we address chronic disorders and chronic illnesses

What is Chronic Fatigue Syndrome (ME/CFS), and how does it affect patients?

Chronic Fatigue Syndrome, also known as myalgic encephalomyelitis (ME/CFS), is a multisystemic disease that can severely impact various organ systems. Patients often experience debilitating symptoms, including severe neurological pain and cognitive dysfunction. Physical or intellectual exertion can trigger a “crash,” rendering the body almost fully dysfunctional on a cellular level. In extreme cases, individuals may lose the ability to perform basic functions such as speaking or leaving their beds.

“It is extremely difficult to describe how such a body feels. The whole body feeling is gone. body functions are gone,identity is gone,job is gone,friends are gone. Everything is gone that made up for the previous life.”

Director sibylle Dahrendorf

How is ME/CFS diagnosed and what challenges exist in identifying the cause?

ME/CFS diagnosis varies greatly and sometimes may not occur at all. even when a diagnosis is made, determining the causes can be complex, requiring extensive analysis of interactions between symptoms. For example, a high school student diagnosed with ME/CFS might find what starts as a brief absence from school turning into long-term isolation, similar to a life sentance within a confined space.

According to a national estimate by the CDC, around 1.3% of adults in the U.S., approximately 3.3 million people, are currently living with ME/CFS [[3]].

What impact does ME/CFS have on the quality of life for patients and their families?

Patients with ME/CFS often become completely cut off from life, unable to engage in previously normal activities. Documentaries like “Chronically ill, chronically ignored” underline that many patients feel underserved by the healthcare and government systems. This lack of support extends not only to the individual but also deeply impacts their families, disrupting dreams and changing lives.

Asad Khan, a pulmonologist who became critically ill after contracting a viral disease during the COVID-19 pandemic, expressed the dire situation as: “I was in this room, just waited to die.I couldn’t go on like this.” Asad Khan

Patients like Khan sometimes rely on treatments such as apheresis,but availability and insurance coverage remain notable issues [[1]].

Why is ther a need for increased research and funding for ME/CFS?

Despite its debilitating effects, ME/CFS has historically received far less research and funding compared to diseases like cancer. This disparity hampers the development of effective treatments and understanding of the disease. The CDC’s 2021-2022 National Health Interview Survey indicates a significant prevalence of ME/CFS,yet it remains under-researched [[3]].

According to reports, the instances of ME/CFS among Americans range from 836,000 to 2.5 million,but many cases remain undiagnosed [[2]].

What actions can be taken to improve the situation for those affected by ME/CFS?

to improve outcomes for individuals with ME/CFS, there is a need for urgent public health interventions, including biomarker research and sensor-based diagnostic readiness. Increased awareness, governmental support, and investment in research can drive progress. Advanced telehealth systems and compensation funds for researchers and patient support groups can aid in managing this chronic illness more effectively.

as highlighted in the experiences of sarah Boothby and her daughter Maeve, a timely and accurate diagnosis is crucial.Misdiagnoses and uncertainty complicate treatment and emotional strain on families [[1]].